References
Cooper C.W. Recent advances with thyrocalcitonin. Ann. Clin. Lab. Sci. 6: 119, 1976.
Raulais D., Hagaman J., Ontjes D.A, Lundblad R.L., Kingdon H.S. The complete amino acid sequence of rat thyrocalcitonin. Eur. J. Biochem. 64: 607, 1976.
Ontani M., Noda T., Yamauchi H. Isolation, chemical structure and biological properties of ultimobranchial calcitonins of the eel. In: Talmage R.V., Own M., Parsons J.A. (Eds.), Proceedings of the 5th Parathyroid Conference. Excerpta Medica, 1974, Amsterdam, p. 111.
Zeytinoglu F.W., DeLellis R.A., Gagel R.F., Wolfe H.J., Tashjian A.H. Establishment of a calcitonin-producing rat medullary thyroid carcinoma cell line. I. Morphological studies of tumor and cells in culture. Endocrinology 107: 509, 1980.
Birnbau R.S., Muszynsk M., Roos B.A. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma. Cancer Res. 40: 4192, 1980.
Leong J.S., Horoszewicz J.S., Shimuoka K., Friedman M., Kawinski E., Song H.J., Ziegel R., Chu T.M., Baylin S., Mirand E.A. A new cell line for study of human medullary thyroid carcinoma In: Andreoli M., Monaco F., Robbins J. (Eds.), Advances in thyroid neoplasia. Field Education Italia, Roma, 1981, p. 95.
Jacobs J.W., Potts J.T. Jr., Bell N.H., Habener J.F. Calcitonin precursor identified by cell-free translation of mRNA. J. Biol. Chem. 254: 10600, 1979.
Rosenfeld M.G., Amara S.G., Roos B.A., Ong E.S., Evans R.M. Altered expression of calcitonin gene associated with RNA polymorphism. Nature 290: 63, 1981.
Jacobs J.W., Lund P.K., Potts J.T. Jr., Bell N.H., Habener J.F. Procalcitonin is a glycoprotein. J. Biol. Chem. 256: 2803, 1981.
Jacobs J.W., Goodman R.H., Chin W.W., Lee P.C., Habener J.F. Calcitonin messenger RNA encodes multiple polypeptides in a single precursor. Science 213: 457, 1981.
Roos B.A., Birnbaum R.S., O’Neil J.A., Aron D.C., Ong E.S., Evans R.M., Amara S.G., Rosenfeld M.G. Cellular and molecular aspects of calcitonin synthesis by rat medullary thyroid carcinoma. In: Pecile A. (Ed.), Calcitonin 1980, chemistry, physiology, pharmacology and clinical aspects. Excerpta Medica, Amsterdam, 1981, p. 25.
Habener J.F., Lund P.K., Jacobs J.W., Dee P.C., Goodman R.H. Polyprotein precursors of regulatory peptides. In: Ditrich E., Gross E. (Eds.), Peptides synthesis, structure and function. Proceedings of the 7th American Peptide Symposium. Pierce Chemical Co., 1981, p. 457.
Hirsch P.F., Voelkel E.F., Munson P.L. Thyrocalcitonin: hypercalcemic, hypophosphatemic principle of the thyroid gland. Science 146: 413, 1964.
Clark M.B., Boyd G.W., Byfield P.G., Foster G.V. A radioimmunoassay for human calcitonin. Lancet 2: 74, 1969.
Tashjian A.H. Jr., Howland B.G., Kenneth B.A., Melvin E.W., Hill C.S. Jr. Immunoassay of human calcitonin. N.Engl. J. Med. 283: 890, 1970.
Deftos L.J., Bury A.E., Habener J.F., Singer F.R., Potts J.T. Jr. Immunoassay for human calcitonin. II. Clinical Studies. Metabolism 20: 1129, 1971.
Heath H., III, Sizemore G.W. Plasma calcitonin in normal man. J.Clin. Invest. 60: 1135, 1977.
Parthemore J.G., Deftos L.J. Calcitonin secretion in normal human subjects. J. Clin. Endocrinol. Metab. 47: 184, 1978.
Sizemore G.W., Heath H., III. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thyroid carcinoma. J. Clin. Invest. 55: 1111, 1975.
Glotzman D., Tischler A.S. Characterization of the immunochemical forms of calcitonin released by medullary thyroid carcinoma in tissue culture. J.Clin. Invest. 61: 449, 1978.
Heersche J.N.M., Marcus R., Aurbach G.D. Calcitonin and the formation of 3′, 5′-AMP in bone and kidney. Endocrinology 94: 241, 1974.
Ham J., Williams J.C., Ellison M.L. Radioreceptor assay for the detection of biologically active forms of calcitonin. J. Endocrinol. 81: 152P, 1979.
Tashjian A.H. Jr., Wright D.R., Ivey J.L., Pont A. Calcitonin binding sites in bone: Relationships to biological response and “escape”. Recent Prog. Horm. Res. 34: 285, 1978.
Wolfe H.J., Melvin K.E.N., Cervi-Skinner S.J., Al Saade A.A., Julian J.F., Jackson C.E., Tashjian A.H. Jr. C-cell hyperplasia preceding medullary thyroid carcinoma. N.Engl. J. Med. 289: 437, 1973.
DeLellis R.A., May L., Tashjian A.H. Jr., Wolfe H.J. C-cell granule heterogeneity in man: An ultrastructural immunocytochemical study. Lab. Invest. 38: 523, 1978.
Roth J., Ravazzola M., Bendayan M., Orci L. Application of the protein A-gold technique for electron microscopic demonstration of polypeptide hormones. Endocrinology 108: 247, 1981.
Galante L.T., Gudmundsson N., Matthews E.W. Thymic and parathyroid origin of calcitonin in man. Lancet 2: 537, 1968.
Kaplan E.L., Peskind G.W., Arnaud C.D. Nonsteroid, calcitonin-like factor from the adrenal gland. Surgery 66: 167, 1969.
Deftos L.J., Burton D., Bone H.G., Catherwood B.D., Parthemore J.G., Moore R.Y., Minick S., Guillemin R. Immunoreactive calcitonin in the intermediate lobe of the pituitary gland. Life Sci. 33: 743, 1978.
Becker K.L., Snider R.J., Moore C.F., Monaghan K.G., Silva O.L. Calcitonin in extrathyroidal tissues of man. Acta Endocrinol. (Kbh.) 92: 746, 1979.
DeLellis R.A., Nunnemacher G., Wolfe H.J. C-cell hyperplasia: An ultrastructural analysis. Lab. Invest. 36: 237, 1977.
Wolfe H.J., Voelkel E.F., Tashjian A.H. Jr. Distribution of calcitonin containing cells in the normal adult human thyroid gland. A correlation of morphology with peptide content. J. Clin. Endocrinol. Metab. 38: 688, 1974.
Van Noorden S., Polak J.M., Pearse A.G.E. Single cellular origin of somatostatin and calcitonin in the rat thyroid gland. Histochemistry 53: 243, 1977.
O’Briain D.S., DeLellis R.A., Wolfe H.J., Reichlin S., Bollinger J., Tashjian A.H. Jr. Somatostatin immunoreactive cells in C-cell hyperplasia and medullary thyroid carcinoma in the rat. Lab. Invest. 40: 275, 1979, (Abstract).
Alumets J., Hakanson R., Lundquvist G., Sundler F., Thorell J. Ontogeny and ultrastructure of somatostatin and calcitonin cells in the thyroid gland of the rat. Cell Tissue Res. 206: 193, 1980.
Gordin A., Lamberg B.A., Pelkonen R., Almqvist S. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid. Clin. Endocrinol. (Oxf.) 8: 289, 1978.
Williams G.A., Hargis G.K., Ensinck J.W., Kukreja S.C., Bowser E.M., Chertow B.S., Henderson W.J. Role of endogenous somatostatin in the secretion of parathyroid hormone and calcitonin. Metabolism 28: 950, 1979.
Huwyler R., Born W., Ohnhaus E.E., Fisher J.A. Plasma kinetics and urinary excretion of oxogenous human and salmon calcitonin in man. Am. J. Physiol. 236: E15, 1979.
Voelkel E.F., Tashjian A.H. Jr. Measurement of thyrocalcitonin-like activity in urine of patients with medullary carcinoma. J. Clin. Endocrinol. Metab. 32: 102, 1971.
Snider R.H., Moore C.F., Silva O.L., Becker K.L. Radioimmunoassay of calcitonin in normal human urine. Anal. Chem. 50: 449, 1978.
Ardaillou R. Kidney and calcitonin. Nephron 15: 250, 1975.
Baylin S.B., Bailey A.L., Hsu T.H., Foster G.V. Degradation of human calcitonin in human plasma. Metabolism 26: 1345, 1977.
Graze K., Spiler I.J., Tashjian A.H. Jr., Melvin K.E.W., Cervi-Skinner S., Gagel R.F., Miller H., Wolfe H.J., DeLellis R.A., Leape L., Feldman Z., Reichlin S. Natural history of familial medullary thyroid carcinoma. Effect of a program for early diagnosis. N.Engl. J. Med. 299: 980, 1978.
Deftos L.J., Roos B.A., Knecht G.L., Lee J.C., Pavlinac D., Bone H.G., Parthemore J.G. In: Copp D.H., Talmage R.V. (Eds.), Endocrinology of calcium metabolism. Excerpta Medica, Amsterdam, Oxford, 1978, p. 134.
Care A.D., Bruce J.B., Boelkins J., Kenney A.D., Conaway H., Anast C.A. Role of Pacreozymin-cholecystokinin and structurally related compounds as calcitonin secretagogues. Endocrinology 89: 262, 1971.
Sizemore G.W., Go V.L.W. Stimulation tests for diagnosis of medullary thyroid carcinoma. Mayo Clin. Proc. 50: 53, 1975.
Bell N.H. Further studies on the regulation of calcitonin release in vitro. Horm. Metab. Res. 7: 77, 1975.
Metz S.A., Deftos L.J., Baylink D.J., Robertson R.P. Neuroendocrine modulation of calcitonin and parathyroid hormone in man. J. Clin. Endocrinol. Metab. 47: 151, 1978.
Vora N.M., Wiliams G.A., Hargis E., Bowser E.N., Kawahara W., Jackson B.L., Henderson W.J., Kukreja S.C. Comparative effect of calcium and of the adrenergic system on calcitonin secretion in man. J. Clin. Endocrinol. Metab. 46: 567, 1978.
Heath H. III. Provocative tests of parathyroid and C-cell function in adrenal-ectomized and chemically simpathectomized rats. Endocrinology 7: 977, 1980.
Rosenfeld M.G., Lin C.R., Amara S.G., Stolarsky L., Roos B.A., Ong E.S., Evans R.M. Calcitonin mRNA polymorphism: Peptide switching associated with alternative RNA splicing events. Proc. Natl. Acad. Sci. USA 79: 1717, 1982.
Miller S.C. Osteoclast cell-surface changes during the egg-laying cycle in Japanese quail, J. Cell Biol. 75: 104, 1977.
Miller S.C. Rapid activation of the medullary bone osteoclast cell surface by parathyroid hormone. J. Cell Biol. 76: 615, 1978.
Weiss R.E., Singer F.R., Gorn A.H., Hofer D.P., Nimni M.E. Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis. J.Clin. Invest. 60: 815, 1981.
Gray T.K., Brannan P., Juan D., Morawski S.G., Fordtran J.S. Ion transport changes during calcitonin-induced intestinal secretion man. Gastroenterology 71: 392, 1976.
Stevenson J.C., Evans I.M.A. Pharmacology and therapeutic use of calcitonin. Drugs 21: 257, 1981.
Deftos L.J., Weisman M.H., Williams G.W., Karpf D.B., Frumar A.M., Davidson B.J., Parthemore J.G., Judd H.L. Influence of age and sex on plasma calcitonin in human beings. N.Engl. J. Med. 302: 1351, 1980.
Wallach S., Cohn S.H., Atkins H.L., Ellis K.J., Kohnberger R., Aloia J.F., Zani I. Ion transport changes during calcitonin induced intestinal secretion in man. Curr. Ther. Res. 22: 556, 1977.
Jowsey J., Riggs B.L., Kelly P.J., Hoffman D.L. Calcium and salmon calcitonin in treatment of osteoporosis. J. Clin. Endocrinol. Metab. 47: 633, 1978.
Chestnut C.H. III, Baylink D.J., Roos B.A., Gruber H.E., Ivey J.L., Matthews M., Nelp W.B., Sisom K. Calcitonin and postmenopausal osteoporosis. In: Pecile A. (Ed.), Calcitonin 1980, chemistry, physiology, pharmacology and clinical aspects. Excerpta Medica, Amsterdam, 1981, p. 247.
Myhre L., Hongslo C.F., Gautvik K.M., Ekeland A. Effect on different calcium intakes on bone mineral composition in rats with a calcitonin secreting tumour. Acta Endocrinol. (Kbh.) 97: 384, 1981.
Wolfe H.J., DeLellis R.A. Familial medullary thyroid carcinoma and C-cell hyperplasia. In: Williams E.D. (Ed.), Pathology and management of thyroid disease. Clin. Endocrinol. Metab. 40: 351, 1981.
Schwartz K.E., Wolfsen A.R., Forster B., Odell W.D. Calcitonin in nonthyroidal cancer. J. Clin. Endocrinol. Metab. 49: 438, 1979.
Roos B.A., Lindall A.W., Baylin S.B., O’Neil J., Frelinger Al., Birnbaum R.S., Lambert P.W. Plasma immunoreactive calcitonin in lung cancer. Endocr. Res. Commun. 6: 169, 1979.
Silva O.L., Broder L.E., Doppman J.L., Snider R.H., Moore C.F., Cohen M.H., Becker K.L. Calcitonin as a marker for bronchogenic cancer — a prospective study. Cancer 44: 680, 1979.
Wolfe H.J. Tumor cell markers: A biological shell game? N.Engl. J. Med. 299: 146, 1978.
Carey D.W., Jones K.L., Parthemore J.G., Deftos L.J. Calcitonin secretion in congenital nongoitrous cretinism. J.Clin. Invest. 65: 892, 1980.
Gagel R.F., Voelkel E.F., Wolfe H.J., DeLellis R.A., O’Briain D.S. Pituitary calcitonin-like material: Radioimmunoassay and immunohistochemical studies. (Abstract). 61 st Annual Meeting of the Endocrine Society. Endocrinology 1979, p. 87.
Flynn J.J., Margules D.L., Cooper C.W. Presence of immunoreactive calcitonin in the hypothalamus and pituitary lobes of rats. Brain Res. Bull. 6: 547, 1981.
Samaan N.A., Leavens M.E. Calcitonin-like immunoreactivity in the pituitary vascular bed of man. J. Clin. Endocrinol. Metab. 53: 985, 1981.
Rizzo A.J., Glotzman D. Calcitonin receptors in the central nervous system of the rat. Endocrinology 108: 1672, 1981.
Galan F., Rogers R.M., Girgis S.I., Macintyre I. Immunoreactive calcitonin in the central nervous system of the pigeon. Brain Res. 212: 59, 1981.
Freed W.J., Bing L.A., Wyatt R.J. Calcitonin: Aversive effects in rats? Science 211: 733, 1981.
Pavlvinac D.M., Lenhard L.W., Parthemore J.G., Deftos L.J. Immunoreactive calcitonin in human cerebrospinal fluid. J. Clin. Endocrinol. Metab. 50: 717, 1980.
Nakanishi S., Kita T., Inoue A., Nakamura M., Chang A.C.Y., Cohen S.N., Numa S. Nucleotide sequence of cloned cDNA for bovine corticotrophin — lipoprotein. Nature 278: 423, 1979.
Jacobs J.W., Simpson E., Goltzman D., Habener D.H. Search for extrathyroidal calcitonin biosynthesis with cloned calcitonin cDNA probes. Clin. Res. 29: 871 A, 1981, (Abstract).
Author information
Authors and Affiliations
Additional information
This work supported by USPHS Grant, National Cancer Institute, 2R25 CA 1 7983
Plenary lecture, XIX Meeting of the Italian Society of Endocrinology, Genova, May 11–14, 1982
Rights and permissions
About this article
Cite this article
Wolfe, H. Calcitonin: perspectives in current concepts. J Endocrinol Invest 5, 423–432 (1982). https://doi.org/10.1007/BF03350544
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350544